Skip Nav Destination
Update search
NARROW
Format
Article Type
Topics
Date
Availability
1-4 of 4
Sort by
News
Published: 2021
News
Published: 2021
Abstract
December 2021
Narendranath Epperla, MD, and Alex F. Herrera, MD, review strategies for incorporating newer targeted immunotherapies into the management of classical Hodgkin lymphoma. This material is repurposed from “How I incorporate novel agents into the treatment of classical Hodgkin lymphoma,” published in the August 19, 2021, edition of Blood .
News
Published: 2021
News
Published: 2021